Earnings History Data for Applied DNA Sciences, Inc. (APDN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Applied DNA Sciences, Inc.

Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market, and sub-license DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
17-12-2024	AH		APDN	Applied DNA Sciences, Inc.	8.38	-0.32	-0.33	-5.20	Applied DNA Sciences GAAP EPS of -$0.32 beats by $0.02, revenue of $0.81M misses by $0.09M [12/17/2024 4:35 PM]	0.2388	0.01 (3.83%)	0.20	-0.03 (-14.87%)	0.12 - 14.40	15,780,324	11,420,000	1,146,885
Applied DNA Sciences GAAP EPS of -$0.32 beats by $0.02, revenue of $0.81M misses by $0.09M [12/17/2024 4:35 PM] Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out [Dec-16-24 10:00AM] Applied DNA Sciences: Fiscal Q4 Earnings Snapshot [2024-12-17 04:12PM] Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines [2024-12-17 04:05PM] Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates [2024-12-17 05:15PM] Applied DNA Customer UHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA [2024-12-18 09:00AM] Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA [2024-12-18 09:00AM]
08-02-2024	AH		APDN	Applied DNA Sciences, Inc.	7.74	-0.09	-0.31	-0.14	Applied DNA Sciences GAAP EPS of -$0.09 beats by $0.22, revenue of $0.89M beats by $0.11M [2/8/2024 5:13 PM]	0.5950	0.0 (-0.83%)	0.62	0.02 (3.33%)	0.52 - 1.86	120,155	60,000	613
Applied DNA Sciences GAAP EPS of -$0.09 beats by $0.22, revenue of $0.89M beats by $0.11M [2/8/2024 5:13 PM]
07-12-2023	AH		APDN	Applied DNA Sciences	14.00	-0.26	-0.27	0.00	Applied DNA Sciences GAAP EPS of -$0.26 beats by $0.01, revenue of $0.78M misses by $0.9M [12/7/2023 5:51 PM]	0.8811	-0.20 (-18.42%)	1.08	0.0 (0.00%)	0.75 - 1.92	144,164	40,000	203
Applied DNA Sciences GAAP EPS of -$0.26 beats by $0.01, revenue of $0.78M misses by $0.9M [12/7/2023 5:51 PM]
10-08-2023	AH		APDN	Applied DNA Sciences, Inc.	20.01	-0.24	-0.24	-0.33	Applied DNA Sciences GAAP EPS of -$0.24 in-line, revenue of $2.92M beats by $0.36M [8/10/2023 5:21 PM]	1.54	-0.21 (-11.71%)	1.74	-0.01 (-0.57%)	0.97 - 4.90	86,345	120,000	624
Applied DNA Sciences GAAP EPS of -$0.24 in-line, revenue of $2.92M beats by $0.36M [8/10/2023 5:21 PM]
11-05-2023	AH	4:10 PM ET (May 11)	APDN	Applied DNA Sciences, Inc.	13.94	-0.20	-0.17	-0.28	Applied DNA Sciences GAAP EPS of $0.05 beats by $0.25, revenue of $4.41M beats by $0.28M [5/11/2023 4:13 PM]	1.09	0.01 (0.93%)	1.11	0.03 (2.78%)	0.62 - 7.35	62,621	70,000	36,067
Applied DNA Sciences GAAP EPS of $0.05 beats by $0.25, revenue of $4.41M beats by $0.28M [5/11/2023 4:13 PM]
09-02-2023	AH	4:10 PM ET (Feb 9)	APDN	Applied DNA Sciences, Inc.	21.94	-0.14	-0.33	-0.63	Applied DNA Sciences GAAP EPS of -$0.30 misses by $0.01, revenue of $5.26M beats by $1.09M [2/9/2023 4:15 PM]	1.65	0.0 (0.00%)	1.65	0.0 (0.00%)	0.62 - 7.35	206,548	150,000	1,623
Applied DNA Sciences GAAP EPS of -$0.30 misses by $0.01, revenue of $5.26M beats by $1.09M [2/9/2023 4:15 PM]
14-12-2022	AH	4:10 PM ET (Dec 12)	APDN	Applied DNA Sciences, Inc.	19.07	N/A	-0.26	-0.49	Applied DNA Sciences GAAP EPS of -$0.93 beats by $0.26, revenue of $18.17M misses by $0.54M [12/14/2022 4:37 PM]	1.40	0.0 (0.00%)	1.36	-0.04 (-2.86%)	0.62 - 7.35	98,420	130,000	5,072
Applied DNA Sciences GAAP EPS of -$0.93 beats by $0.26, revenue of $18.17M misses by $0.54M [12/14/2022 4:37 PM] Applied DNA Announces Fourth Quarter and Fiscal Year 2022 Financial Results [Dec-14-22 04:10PM]
12-05-2022	AH	4:05 PM ET (May 12)	APDN	Applied DNA Sciences, Inc.	10.62	-0.28	-0.30	-0.33	Applied DNA Sciences GAAP EPS of -$0.23 beats by $0.10, revenue of $6.15M beats by $1.65M [5/12/2022 4:09 PM]	1.38	0.14 (11.30%)	1.41	0.17 (13.71%)	1.08 - 8.10	12,197	40,000	217
Applied DNA Sciences GAAP EPS of -$0.23 beats by $0.10, revenue of $6.15M beats by $1.65M [5/12/2022 4:09 PM] Applied DNA Reports Second Quarter Fiscal 2022 Financial Results [May-12-22 04:05PM] Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates [May-12-22 06:25PM]
10-02-2022	AH	4:05 PM ET (Feb 10)	APDN	Applied DNA Sciences, Inc.	25.15	-0.63	-0.19	-0.62	Applied DNA Sciences GAAP EPS of -$0.63, revenue of $4.17M [2/10/2022 4:35 PM]	2.61	-0.50 (-16.08%)	2.85	-0.26 (-8.36%)	2.55 - 13.64	322,093	70,000	11,568
Applied DNA Sciences GAAP EPS of -$0.63, revenue of $4.17M [2/10/2022 4:35 PM] Applied DNA slips despite a two-fold rise in Q1 revenue as cost base expands [2/11/2022 12:24 PM] Applied DNA First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues [Feb-10-22 04:05PM] Applied DNA Sciences (APDN) Reports Q1 Loss, Lags Revenue Estimates [Feb-10-22 06:05PM]
09-12-2021	AH	4:05 PM ET (Dec 9)	APDN	Applied DNA Sciences, Inc.	38.70	-0.49	-0.31	-0.82	Applied DNA Sciences EPS misses by $0.23, beats on revenue [12/9/2021 4:07 PM]	4.91	-0.17 (-3.39%)	5.13	0.05 (0.98%)	4.65 - 13.64	744,444	1,350,000	265,050
Applied DNA Sciences price target lowered at H.C. Wainwright despite revenue beat [12/10/2021 12:28 PM] Applied DNA Reports Fourth Quarter and Full Fiscal Year 2021 Financial Results, Continuing Momentum in Diagnostic Testing [Dec-09-21 04:05PM] Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates [Dec-10-21 01:57AM]
12-08-2021	AH	4:10 PM ET (Aug 12)	APDN	Applied DNA Sciences, Inc.	47.54	-0.46	-0.23	-0.72	Applied DNA Sciences EPS misses by $0.20, misses on revenue [8/12/2021 4:55 PM]	6.00	-0.20 (-3.23%)	6.22	0.02 (0.32%)	4.95 - 13.64	1,144,608	3,030,000	7,744
Applied DNA Sciences EPS misses by $0.20, misses on revenue [8/12/2021 4:55 PM] Applied DNA Announces Third Quarter Fiscal 2021 [Aug-12-21 04:05PM] Applied DNA Sciences (APDN) Reports Q3 Loss, Lags Revenue Estimates [Aug-12-21 06:35PM]
13-05-2021	AH	4:05 PM ET (May 13)	APDN	Applied DNA Sciences, Inc.	49.85	-0.33	-0.18	-0.79	Applied DNA Sciences EPS in-line, beats on revenue [5/13/2021 4:25 PM]	6.15	0.22 (3.78%)	6.02	0.09 (1.52%)	4.95 - 16.39	305,989	1,690,000	4,870
Applied DNA Sciences EPS in-line, beats on revenue [5/13/2021 4:25 PM] FDA Grants EUA to Applied DNA LineaTM COVID-19 Assay Kit for Asymptomatic Screening of Individuals with Serial Testing [May-12-21 09:35AM] Applied DNA Sciences, Inc. to Host Earnings Call [May-13-21 02:30PM] Applied DNA Second Fiscal Quarter 2021 Financial Results Feature 384% Year-Over-Year Growth in Revenues [May-13-21 04:10PM] Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates [May-13-21 08:05PM] Applied DNA Provides Clarification on Newly Authorized Asymptomatic Serial Screening Indication for LineaTM COVID-19 Assay Kit and Press Release Published 12 May 2021 [May-13-21 09:51PM]
11-02-2021	AH	4:05 PM ET (Feb 11)	APDN	Applied DNA Sciences, Inc.	81.21	-0.62	-0.55	-1.12	Applied DNA Sciences EPS misses by $0.34, beats on revenue [2/11/2021 4:17 PM]	11.75	-0.82 (-6.52%)	10.65	-1.92 (-15.27%)	2.52 - 16.39	1,253,644	1,459,545	161,051
Applied DNA Sciences EPS misses by $0.34, beats on revenue [2/11/2021 4:17 PM] Applied DNA Reports First Fiscal Quarter 2021 Revenues at Upper End of Guided Range [Feb-11-21 04:05PM] Applied DNA Sciences, Inc. to Host Earnings Call [Feb-11-21 02:30PM] Applied DNA and Cytocheck Detect First Instance of SARS-CoV-2 B.1.1.7 Variant in Kansas [Feb-11-21 07:00AM]
17-12-2020	AH	4:05 PM ET (Dec 17)	APDN	Applied DNA Sciences, Inc.	31.89	-0.82	-0.59	-1.44	Applied DNA Sciences EPS misses by $0.30, misses on revenue [12/17/2020 4:19 PM]	5.20	-1.04 (-16.75%)	5.26	-0.98 (-15.71%)	2.52 - 16.39	840,548	586,762	73,943
Applied DNA Sciences EPS misses by $0.30, misses on revenue [12/17/2020 4:19 PM] Applied DNA bags surveillance testing contract of up to $2M from Suffolk County Government [12/17/2020 1:22 PM] Applied DNA Sciences (APDN) Reports Q4 Loss, Misses Revenue Estimates [Dec-17-20 05:35PM] Recap: Applied DNA Sciences Q4 Earnings [Dec-17-20 04:14PM]
06-08-2020	AH	4:05 PM ET (Aug 6)	APDN	Applied DNA Sciences, Inc.	45.33	-0.72	-0.62	-1.60	Applied DNA Sciences EPS misses by $0.04, misses on revenue [8/6/2020 4:10 PM]	9.87	-1.10 (-10.03%)	9.93	-1.04 (-9.48%)	2.52 - 19.69	472,613	2,429,807	18,930